CVE-2020-27260 : What You Need to Know

Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15 is affected by HL7 v2.x injection vulnerabilities that allow attackers to inject segments into specific messages.

Understanding CVE-2020-27260

This CVE involves improper neutralization of special elements in output used by a downstream component, leading to HL7 v2.x injection vulnerabilities.

What is CVE-2020-27260?

The vulnerability in the affected product allows physically proximate attackers with a connected barcode reader to inject HL7 v2.x segments into specific messages through expected parameters.

The Impact of CVE-2020-27260

Attackers can manipulate HL7 v2.x messages, potentially leading to unauthorized access or data manipulation.

Technical Details of CVE-2020-27260

The following technical details provide insight into the vulnerability.

Vulnerability Description

HL7 v2.x injection vulnerabilities in Innokas Yhtymä Oy Vital Signs Monitor VC150 prior to Version 1.7.15.

Affected Systems and Versions

Product: BIGCOMPANYSOFT SOFTWARE PRODUCT
Version: VC150 prior to Version 1.7.15

Exploitation Mechanism

Physically proximate attackers with a connected barcode reader can inject HL7 v2.x segments into specific messages.

Mitigation and Prevention

Taking immediate steps and implementing long-term security practices are crucial to mitigate the risks associated with CVE-2020-27260.

Immediate Steps to Take

Update the affected software to Version 1.7.15 or later.
Implement network segmentation to limit access to vulnerable systems.

Long-Term Security Practices

Regularly monitor and audit HL7 messages for anomalies.
Train employees on identifying and reporting suspicious activities.

Patching and Updates

Apply patches and updates provided by the vendor to address the vulnerability.